| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alexander Staruschenko | |
| Tengis S Pavlov | |||
| John D Imig | |||
| P2860 | cites work | Relationship between PPARalpha activation and NO on proximal tubular Na+ transport in the rat | Q24799696 |
| Structure and regulation of amiloride-sensitive sodium channels | Q28137896 | ||
| The organization, promoter analysis, and expression of the human PPARgamma gene | Q28244071 | ||
| Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat | Q28271669 | ||
| Expression of peroxisomal proliferator-activated receptors and retinoid X receptors in the kidney | Q28377689 | ||
| Fat and beyond: the diverse biology of PPARgamma | Q29615416 | ||
| P-450 metabolites of arachidonic acid in the control of cardiovascular function | Q29620578 | ||
| Increased renin production in mice with deletion of peroxisome proliferator-activated receptor-gamma in juxtaglomerular cells. | Q30433046 | ||
| Epithelial sodium channel regulated by aldosterone-induced protein sgk. | Q30650629 | ||
| Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney. | Q30712385 | ||
| Role of 20-HETE in mediating the effect of dietary K intake on the apical K channels in the mTAL. | Q32032052 | ||
| Peroxisome proliferator-activated receptors: from genes to physiology | Q32120242 | ||
| Pharmacological correction of a defect in PPAR-gamma signaling ameliorates disease severity in Cftr-deficient mice | Q33712428 | ||
| CYP-omega-hydroxylation-dependent metabolites of arachidonic acid inhibit the basolateral 10 pS chloride channel in the rat thick ascending limb | Q33819431 | ||
| Collecting duct-specific deletion of peroxisome proliferator-activated receptor gamma blocks thiazolidinedione-induced fluid retention | Q33878917 | ||
| Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation | Q34088380 | ||
| Thiazolidinediones | Q34346862 | ||
| Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel | Q34524859 | ||
| Collecting duct-specific gene inactivation of alphaENaC in the mouse kidney does not impair sodium and potassium balance. | Q35242835 | ||
| Thiazolidinediones, Peripheral Edema, and Type 2 Diabetes: Incidence, Pathophysiology, and Clinical Implications | Q35570243 | ||
| The epithelial sodium channel: from molecule to disease | Q35775040 | ||
| New insights into the role of serum- and glucocorticoid-inducible kinase SGK1 in the regulation of renal function and blood pressure. | Q35977199 | ||
| Arachidonic acid inhibits epithelial Na channel via cytochrome P450 (CYP) epoxygenase-dependent metabolic pathways | Q36445744 | ||
| Roles of the cytochrome P450 arachidonic acid monooxygenases in the control of systemic blood pressure and experimental hypertension. | Q36863470 | ||
| The next generation of PPAR drugs: do we have the tools to find them? | Q36865782 | ||
| Epoxyeicosatrienoic acid activates BK channels in the cortical collecting duct | Q37123270 | ||
| Thiazolidinedione-induced fluid retention is independent of collecting duct alphaENaC activity. | Q37146413 | ||
| Anti-inflammatory therapies for cystic fibrosis-related lung disease | Q37188760 | ||
| Mechanisms of ENaC regulation and clinical implications | Q37254732 | ||
| Arachidonic acid inhibits basolateral K channels in the cortical collecting duct via cytochrome P-450 epoxygenase-dependent metabolic pathways. | Q37325209 | ||
| Significance of peroxisome proliferator-activated receptors in the cardiovascular system in health and disease | Q37422668 | ||
| Review article: importance of the kidney proximal tubular cells in thiazolidinedione-mediated sodium and water uptake | Q37483785 | ||
| Chronic rosiglitazone therapy normalizes expression of ACE1, SCD1 and other genes in the kidney of obese Zucker rats as determined by microarray analysis | Q38288308 | ||
| Effects of peroxisome proliferator-activated receptor gamma agonists on Na+ transport and activity of the kinase SGK1 in epithelial cells from lung and kidney | Q39253544 | ||
| Localization of cytochrome P-450 4A isoforms along the rat nephron. | Q50905151 | ||
| Troglitazone in combination with sulfonylurea restores glycemic control in patients with type 2 diabetes. The Troglitazone Study Group. | Q51568191 | ||
| Functional reconstitution of the human epithelial Na+ channel in a mammalian expression system. | Q51804605 | ||
| PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial cells from spontaneously hypertensive rats. | Q53541771 | ||
| Role of oxidative stress in cardiac dysfunction of PPARα−/− mice | Q57907080 | ||
| Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC | Q79930264 | ||
| Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure | Q80313208 | ||
| Deletion of peroxisome proliferator-activated receptor-alpha induces an alteration of cardiac functions | Q82482440 | ||
| PPARgamma agonists, modulation of ion transporters, and fluid retention | Q84699186 | ||
| PPARgamma agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line | Q39858791 | ||
| Renal and vascular mechanisms of thiazolidinedione-induced fluid retention | Q40048496 | ||
| Peroxisome proliferator-activated receptor-gamma is involved in the control of renin gene expression. | Q40085415 | ||
| PPARgamma agonists do not directly enhance basal or insulin-stimulated Na(+) transport via the epithelial Na(+) channel | Q40371669 | ||
| Epithelial sodium channels: function, structure, and regulation | Q41441322 | ||
| PPARgamma Agonists: Blood Pressure and Edema | Q41876733 | ||
| Peroxisome proliferator-activated receptor gamma antagonists decrease Na+ transport via the epithelial Na+ channel. | Q42459811 | ||
| Induction of P4504A activity improves pressure-natriuresis in Dahl S rats | Q42545245 | ||
| Cytochrome P-450 metabolites mediate extracellular Ca(2+)-induced inhibition of apical K+ channels in the TAL. | Q42636563 | ||
| Regulation of ENaC expression at the cell surface by Rab11. | Q43214929 | ||
| Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells | Q43646691 | ||
| Structure, endothelial function, cell growth, and inflammation in blood vessels of angiotensin II-infused rats: role of peroxisome proliferator-activated receptor-gamma | Q43993728 | ||
| Arachidonic acid inhibits K channels in basolateral membrane of the thick ascending limb | Q44094395 | ||
| Regulation of blood pressure, natriuresis and renal thiazide/amiloride sensitivity in PPARalpha null mice | Q44239626 | ||
| PPARgamma ligands induce prostaglandin production in vascular smooth muscle cells: indomethacin acts as a peroxisome proliferator-activated receptor-gamma antagonist | Q44535771 | ||
| PPARgamma activation enhances cell surface ENaCalpha via up-regulation of SGK1 in human collecting duct cells | Q44552034 | ||
| Rosiglitazone Activates Renal Sodium- and Water-Reabsorptive Pathways and Lowers Blood Pressure in Normal Rats | Q44639239 | ||
| Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity | Q44669024 | ||
| Regulation of cytochrome P-450 4A activity by peroxisome proliferator-activated receptors in the rat kidney | Q44721703 | ||
| Decreased expression of peroxisome proliferator activated receptor gamma in cftr-/- mice. | Q44918616 | ||
| Ras activates the epithelial Na(+) channel through phosphoinositide 3-OH kinase signaling | Q44950440 | ||
| Expression of peroxisome proliferator-activated receptor isoform proteins in the rat kidney. | Q44978025 | ||
| GI262570, a peroxisome proliferator-activated receptor {gamma} agonist, changes electrolytes and water reabsorption from the distal nephron in rats | Q45099493 | ||
| Activation of PPARgamma by rosiglitazone attenuates intestinal Cl- secretion. | Q46011310 | ||
| The role of Sgk-1 in the upregulation of transport proteins by PPAR-{gamma} agonists in human proximal tubule cells | Q46255897 | ||
| Regulation of the renal thiazide-sensitive Na-Cl cotransporter, blood pressure, and natriuresis in obese Zucker rats treated with rosiglitazone | Q46425687 | ||
| Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption | Q46592677 | ||
| NAD(P)H oxidase/nitric oxide interactions in peroxisome proliferator activated receptor (PPAR)alpha-mediated cardiovascular effects | Q46626533 | ||
| Renal cytochrome P450 as a determinant of impaired natriuresis by PPAR-gamma ligands in ovariectomized obese rats | Q46752165 | ||
| Adenosine inhibits ENaC via cytochrome P-450 epoxygenase-dependent metabolites of arachidonic acid | Q46761419 | ||
| Lack of the serum and glucocorticoid-inducible kinase SGK1 attenuates the volume retention after treatment with the PPARgamma agonist pioglitazone | Q46825295 | ||
| Expression of peroxisome proliferator-activated receptors in urinary tract of rabbits and humans | Q48041011 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P304 | page(s) | 703735 | |
| P577 | publication date | 2010-06-14 | |
| P1433 | published in | PPAR Research | Q15756406 |
| P1476 | title | Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors | |
| P478 | volume | 2010 |
| Q42811249 | Characterization of telmisartan-derived PPARγ agonists: importance of moiety shift from position 6 to 5 on potency, efficacy and cofactor recruitment |
| Q34828709 | Collecting duct principal cell transport processes and their regulation |
| Q61448170 | Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics |
| Q47785505 | Pioglitazone Improves Left Ventricular Diastolic Function in Subjects With Diabetes. |
| Q36945118 | Regulation of ENaC in mice lacking renal insulin receptors in the collecting duct |
| Q92503973 | Rosiglitazone promotes ENaC-mediated alveolar fluid clearance in acute lung injury through the PPARγ/SGK1 signaling pathway |
| Q26741611 | Serum and Glucocorticoid Regulated Kinase 1 in Sodium Homeostasis |
| Q27015001 | Sodium-retaining effect of insulin in diabetes |
| Q38090700 | Therapeutic potential of serum and glucocorticoid inducible kinase inhibition |
| Q36734040 | Thiazolidinedione-induced fluid retention: recent insights into the molecular mechanisms. |
Search more.